Stock Earnings
Stoke Therapeutics Inc (STOK) Becoming More Attractive for Investors
Stoke Therapeutics Inc’s recently made public that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $52379.0 on
Menu
Stoke Therapeutics Inc’s recently made public that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $52379.0 on
Moleculin Biotech Inc’s recent filing unveils that its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0
In a filing, Alnylam Pharmaceuticals Inc revealed its Chief Executive Officer Greenstreet Yvonne unloaded Company’s shares for reported $9.63 million
Evolus Inc’s filing revealed that its insider MOATAZEDI DAVID unloaded Company’s shares for reported $1.12 million on Jun 13 ’25.
Insulet Corporation’s recently made public that its SVP, Global Operations Singh Prem unloaded Company’s shares for reported $0.7 million on
Chewy Inc’s recent filing unveils that its 10% Owner Argos Holdings GP LLC unloaded Company’s shares for reported $1.25 billion
In a filing, BJ’s Wholesale Club Holdings Inc revealed its Officer Cichocki Paul acquired Company’s shares for reported $14.27 million
Sonos Inc’s filing revealed that its 10% Owner Coliseum Capital Management, L acquired Company’s shares for reported $2.36 million on
Acadia Pharmaceuticals Inc’s recently made public that its Director Brege Laura unloaded Company’s shares for reported $0.31 million on Jun
Grindr Inc’s recent filing unveils that its GC and Head of Global Affairs Katz Zachary unloaded Company’s shares for reported